By culturing neural progenitor cells in the presence of retinoid receptor agonists, we have defined the components of the retinoidsignalling pathway that are important for the birth and maintenance of neuronal cells. We provide evidence that depending on the order and combination of retinoid receptors activated, different neuronal cells are obtained. Astrocytes and oligodendrocytes are predominantly formed in the presence of activated retinoic acid receptor (RAR) a, whereas motoneurons are formed when RARh is activated. We have looked at the regulation of two transcription factors islet-1/2 which are involved in neuronal development. We find that activated RARh up-regulates islet-1 expression, whereas activation of RARa can either act in combination with RARh signalling to maintain islet-1 expression or induce islet-2 expression in the absence of activated RARh. RARg cannot directly regulate islet-1/2 but can down-regulate RARh expression, which results in loss of islet-1 expression. We finally show that activated RARa is one of the final steps required for a mature motoneuron phenotype.
Introduction
Recently there has been much interest in defining the pathways required to differentiate stem cells into a particular fate, so that the resultant cells can be used to replace damaged or diseased tissue. For example, embryonic stem (ES) cells can be forced to differentiate into macrophages, mast cells or neutrophils by IL-3 (Wiles and Keller, 1991) and muscle cells by transforming growth factor (TGF) (Schuldiner et al., 2000; Slager et al., 1993) . Retinoic acid (RA) can cause the differentiation of stem cells into three different lineages; astrocytes, oligodendrocytes and neurons (Arnhold et al., 2000; Jang et al., 2004; Qu et al., 2003; Wohl and Weiss, 1998) .
Retinoid signalling is mediated by retinoic acid receptors (RARs) and the retinoid X receptors (RXRs), of which there are three subtypes of each; a, h and g (Bastien and Rochette-Egly, 2004) . Further isoforms of these receptors are obtained by alternative splicing and differential promoter usage (Leid et al., 1992) . Transcription occurs when RA binds to an RAR/RXR heterodimer, which then binds to retinoic acid response elements (RAREs), located in the regulatory regions of target genes (Bastien and Rochette-Egly, 2004) .
During differentiation of CNS progenitor cells, retinoids can be detected along the length of the neural tube (Colbert et al., 1993; Maden et al., 1998; McCaffery and Drager, 1994; Rossant et al., 1991) , indicating the importance of retinoid signalling during this process. The function of RA in neuronal differentiation may be carried out by the activation of different RARs, as during development of the mouse cord, RARh, RARa and RXRg are first expressed at E10.5 along the entire anterior posterior (AP) axis (Colbert et al., 1995) . At E12.5, RARh becomes restricted to the cervical and lumbar domains while RARa and RXRg continue to be expressed along the AP axis (Colbert et al., 1995) .
Two transcription factors that are involved in neuronal fate are islet-1 and islet-2, which are members of the LIM homeodomain family (Tsuchida et al., 1994) . Motoneurons are derived from progenitor cells which all initially express islet-1 (Ericson et al., 1992) . In islet-1 null mice, spinal motoneurons do not develop indicating that its expression is critical for motoneuron specification (Pfaff et al., 1996) . Five subtypes of motoneurons are then derived from this progenitor population, four of which express islet-2 (Tsuchida et al., 1994) . RA signalling has been shown to be involved in the initial induction of islet-1 and the subsequent differentiation of some subtypes of motoneurons (Sharpe and Goldstone, 1997; Sockanathan and Jessell, 1998; Sockanathan et al., 2003) , but the RARs involved in these steps are not known.
We have looked at the role of retinoid signalling in the fate of neural progenitor cells (NPCs) and the regulation of two neuronal markers islet-1 and islet-2 by using retinoid receptor-specific agonists. In cultures of NPCs, we show that by activating specific RARs, different neuronal fates can be obtained. Furthermore, depending on the order and combination of activation of retinoid receptors the number of islet-1 and islet-2-expressing neurons are far higher than can be obtained by using RA alone. We finally show that when RARh signalling is activated in motoneurons, neurite outgrowth is obtained while RARa signalling is one of the final steps in their maturation. 
Materials and methods

Culture of neural progenitor cells
The isolation and in vitro propagation of NPCs is based on previously described procedures (Minger et al., 1996) . Briefly, the spinal neural tube ventricular zone was removed at gestational day 14 (E14) from Fischer 344 rat embryos (crown-rump length 9-11 mm) and collected in sterile Dulbecco's phosphate buffered saline (PBS). Tissue was incubated in 0.1% trypsin/PBS for 30 min at 378C, centrifuged at 1000 Â g and resuspended in PBS-glucose three times, then dissociated to a single cell suspension by repeated pipetting through narrowed Pasteur pipettes. Cell viability and density was determined by trypan blue exclusion and haemocytometric counting. Cells were plated at a density of 30,000 cells per well on 13 mm 2 glass coverslips precoated with 10 Ag/ml polyornithine and 10 Ag/ml laminin (Gibco) in 24well plates (Nunc). The cells were grown in DMEM/F12 high glucose media with N2 supplement (Gibco) in 95% air/5% CO2 humidified atmosphere in the presence of 20 In the presence of RARa agonist, the majority of the NPCs differentiated into astrocytes (GFAP-positive cells) and oligodendrocytes (RIP-positive cells), which were significantly greater than those formed in RA. In the presence of the RARh agonist, NPCs mainly differentiated into motoneurons (MNR2/ HB9-positive cells), which were significantly greater than those formed in RA. *P b 0.05, Student's t test. Scale bar: 50 Am. ng/ml FGF-2 for 72 h. The media was then exchanged and supplemented with 0.1 AM of the appropriate retinoid agonist (Corcoran et al., 2000) instead of FGF-2. The agonists used were all trans RA (Sigma) and retinoidspecific agonists obtained from CIRD Galderma, Sophia-Antipolis, France. These were CD366, which activates RARa; CD2019, which activates RARh; CD437, which activates RARg; and CD2809, which activates all RXRs. Culture conditions were carried out three times, using two coverslips per treatment.
In situ hybridisation and immunohistochemistry
Both in situ hybridisation and immunohistochemistry were carried out as previously described (Corcoran et al., 2000) . The antibodies used were obtained from the Developmental Studies Hybridoma Bank (University of Iowa) except where stated. These were, anti-mouse islet-1, anti-mouse islet-2, anti-mouse MNR2, anti-rabbit NF200 (Sigma), anti-mouse GFAP (Chemicon), anti-mouse RIP and anti-mouse p75 (Chemicon). MNR2 staining has been used to identify HB9 and/or HB9 related protein in rat tissue (Takahashi and Osumi, 2002) . Secondary antibodies used were Cy3 and FITC conjugated (Jackson). The cultures were counterstained with DAPI to detect nuclei. Cultures were analysed at a 100Â magnification, images were captured by Image Pro plus software. Neuronal cells were selected for positive signals and either counted or neuronal lengths measured using the computer software. Six random fields of 40 mm 2 of the final magnification were taken per coverslip. Graphs were plotted and statistical analysis carried out using sigma-plot software. Histograms show mean F SEM of either positive neurons/field or average length of neurites (Am). 
Results
NPCs can be isolated from the rat ventricular zone
We first asked if cells isolated from the rat E14 spinal cord ventricular layer have the characteristics of NPCs. These are as follows: firstly, they undergo self-renewal; secondly, they express nestin during this renewal process; and thirdly, they differentiate into various types of cells of the nervous system (Cai et al., 2002; Gage et al., 1995; Maric and Barker, 2004; Minger et al., 1996) . The cells were grown in the presence of the mitogen FGF-2 (20 ng/ml) and they were passaged and counted at 1, 9, 22, 35 and 52 days of culture. They were assessed for neurogenic potential by taking cells at each passage point and culturing them in the presence of 0.10 AM RA for 48 h instead of FGF-2. With increasing time, the number of cultured cells increased from the seeding density of 0.1 million cells/ml to over 400 million cells/ml at 52 days of culture, which was the end point of the experiment (Fig. 1A) . Most, if not all the cells, were positive for nestin at each passage point ( Fig. 1B) . After RA treatment, we found that few, if any, nestinpositive cells remained (Fig. 1C) and three different neural cell types could be obtained. These were astrocytes as shown by GFAP staining (Fig. 1D ), oligodendrocytes as shown by RIP staining (Fig. 1E ) and motoneurons as shown by MNR2/HB9 staining (Fig. 1F) .
RA can activate all three RARs; therefore, we next asked if by activating the RARs individually, particular types of neural cells could be obtained. We used the following receptor-specific agonists: CD366, which activates RARa; CD2019, which activates RARh; and CD437, which activates RARg. The NPCs were cultured for 48 h in FGF-2 and then in 0.10 AM of retinoid agonist, either RARa, RARh or RARg for a further 48 h. In the presence of RARa agonist, the majority of cells were astrocytes (Figs. 2A and J) and oligodendrocytes (Figs. 2B and J), which were significantly greater than those formed in the presence of RA, but there were few motoneurons (Figs. 2C and J) . In contrast, in the presence of RARh agonist, the majority of the cells were motoneurons (Figs. 2F and J), which were significantly greater than those formed in the presence of RA, but there were few astrocytes (Figs. 2D and J) or oligodendrocytes (Figs. 2E and J) . In the presence of the RARg agonist, few, if any, motoneurons could be detected (Figs. 2I and J) and only some astrocytes and oligodendrocytes (Figs. 2G and H), but these were not significantly different to those formed in the presence of RA (Fig. 2J ). These data indicate that the RAR receptor pathways have different roles in the determination of NPCs.
Activation of RARb is required for islet-1 expression
As the majority of motoneurons occur in the RARh agonist-treated cultures, we next asked if RARh, like RA, could regulate islet-1 and islet-2, which are involved in the determination of motoneurons (Sharpe and Goldstone, 1997; Sockanathan and Jessell, 1998; In the presence of RARa or g agonist, very few islet-1 cells were obtained at any dose; while in the presence of RARh agonist, islet-1expressing cells were predominantly formed in 0.1 and 10 AM of the agonist. Similar data were obtained when the cells were cultured in the presence of the agonists for 4 days. Scale bar: 50 Am.
2003).
In the presence of both retinoids, islet-1-expressing cells were obtained (Figs. 3A and C); however, their numbers were significantly higher in the presence of RARh agonist than RA (Fig. 3E) . In contrast, while islet-2expressing cells were obtained with both retinoids (Figs. 3B and D), there were significantly less in RARh agonist than in the RA-treated cultures (Fig. 3E) .
In order to rule out the possibility that the RARh agonist can activate other RARs, and or the other retinoid agonists can activate RARh at particular concentrations, we asked if islet-1-expressing cells could be induced in the NPC cultures with increasing concentrations of the agonists. The NPCs were cultured in FGF-2 for 48 h then were switched to 0.01, 0.1, 1, 10 or 100 AM of either RARa, h or g agonist for a further 48 h. In the presence of the RARa agonist, very few islet-1-positive cells were obtained and these did not increase with increasing dose of agonist (Figs. 4A-D). Similar data were obtained with the NPCs treated with RARg agonist (Figs. 4I-L). In NPCs cultured in RARh agonist, islet-1expressing cells were predominantly formed in the presence of 0.1 and 10 AM of the agonist (Figs. 4F and G) but not in either 0.01 or 100 AM (Figs. 4E and H) . Similar data were obtained when the NPCs were cultured in the presence of the agonists for 4 days rather than 48 h (data not shown). These data suggest that the activation of RARh is responsible for the majority of islet-1 expression in the NPCs and that the other receptor agonists can neither cause a significant increase in this expression, nor activate RARh.
RARa activation maintains islet-1 expression in the presence of RARb activation but induces islet-2 expression in its absence
Previous work has shown that further retinoid signalling via RARs occurs to determine the fate of motoneurons once the islet-1 pool is formed (Sockanathan et al., 2003) and four of the resultant subtypes of motoneurons express islet-2. This retinoid signalling may also be mediated by RXRs, as it has been shown to be involved in the maturation of limb-innervating motor neurons (Solomin et al., 1998) . Therefore, we next asked what effect activating either RARa, g or RXR has on islet-1/2 expression. NPCs were cultured in FGF-2 containing medium for 48 h followed by 0.10 AM RARh agonist for 48 h in order to form islet-1-expressing motoneurons, and then in 0.10 AM of RARa, g or a pan RXR agonist (CD2809) for 48 h in the presence or absence of 0.10 AM RARh agonist. The majority of islet-1 neurons were formed in the RARh plus RARa-treated cultures (Fig.  5A ), and these were significantly greater than in the RARh agonist-treated cultures while the converse was true in RARh plus RARg-treated cultures (Fig. 5E ). In the RARh plus RXR-treated cultures, their numbers were not significantly different compared to the RARh-stimulated cultures (Fig. 5E) .
In contrast, few if any islet-2-expressing neurons could be formed with any of the agonists when RARh agonist was present (Figs. 5B and E). However, in the RARh then RARa agonist-treated cultures, there was a loss of islet-1expressing neurons (Fig. 5C ) and an increase in islet-2expressing neurons (Fig. 5D ), which were significantly greater compared to the combined activation of RARh plus RARa (Fig. 5F ). In the RARh then RARg-treated cultures and RARh then RXR-treated cultures, islet-1expressing neurons were lost (Fig. 5F ) and there were some islet-2-expressing neurons; however, there was no significant difference in their numbers compared to RARh plus RARa-treated cultures (Fig. 5F) . These data indicate that the loss of RARh activation leads to the loss of islet-1 expression and activation of RARa induces islet-2 expression.
Next, we asked if any of the RARs could regulate one another as has been previously shown (Corcoran et al., 2000; Ferrari et al., 1998; Matt et al., 2003) . In RARh plus RARa agonist-treated cultures, all three RARs could be detected by in situ hybridisation (Figs. 6A-C) ; similar data were obtained in the RARh plus pan RXR agonisttreated cultures (Figs. 6G-I) . In contrast, in the RARh plus RARg agonist-treated cultures, there was a loss of RARh expression ( Fig. 6E) while RARa and g expression were maintained (Figs. 6D and F) . This suggests that the RARg agonist can inhibit RARh expression and as a consequence there is a loss of islet-1 expression.
RARa signalling is required to maintain a mature motoneuron phenotype
The above data suggest that motoneurons must initially activate RARh signalling in order to induce islet-1, whereas previously it has been shown that adult motoneurons express RARa rather than RARh (Corcoran et al., 2002) . Mature motoneurons express the low-affinity neurotrophin receptor (p75) (Camu and Henderson, 1992) and they extend neurites containing neurofilaments (Xu et al., 1994) . Therefore, we asked if activation of the RARasignalling pathway could give rise to p75-expressing motoneurons and under what treatments neurites could be formed. In NPC cultures treated with RARh plus either RARa, g or the pan RXR agonist, very little p75 immunoreactivity was detected ( Figs. 7A and E) . In contrast, in NPC cultures treated with RARh then RARa, g or RXR agonist, more p75 motoneurons were formed than in the presence of RARh and a second retinoid agonist (Fig.  7E) . The majority were formed in the RARh then RARa agonist-treated cultures (Fig. 7C) and were significantly greater than in any of the other culture conditions (Fig. 7E ). This suggests that the absence of RARh signalling leads to a mature motoneuron phenotype and that RARa signalling can maintain it.
Neurites were formed in all six culture conditions the longest in the RARh plus RARa (Figs. 7B and F) and RARh then RARa agonist-treated cultures (Figs. 7D and F) . In the RARh plus RARg, RARh then RARg and RARh then RXR agonist-treated cultures, neurite lengths were significantly shorter than RARh plus RARa-treated cultures (Fig. 7F ). There was no significant difference in neurite lengths between RARh plus RXR and RARh plus RARatreated cultures (Fig. 7F ).
Discussion
The CNS is thought to develop from self-renewing stem cells that can generate the three major cell types: oligodendrocytes, astrocytes and neurons (Gage, 2000) . We have shown here that cells obtained from the rat E14 spinal cord ventricular layer have the characteristics of NSCs. They can be expanded in vitro by the mitogen FGF-2 and can differentiate in the presence of RA into the three cell types of the CNS. While RA can activate all the RARs, we have shown by using RAR-specific agonists that RARa signalling predominantly causes the differentiation of NPCs into astrocytes and oligodendrocytes and some are formed in the presence of RARg signalling. In the presence of RARh signalling, NPCs differentiate into motoneurons (Fig. 8) . This increase in neuronal differentiation by RA has also been shown in vivo. The addition of RA to cultured chicken neural tubes (Sockanathan and Jessell, 1998) and overexpression of retinoid receptors in Xenopus embryos causes an increase in the number of neurons (Sharpe and Goldstone, 1997) .
We have not shown that the cells are true stem cells, in that we have not taken a single cell and derived multiple lineages from it; such experiments are difficult to do since single cells do not survive well in culture. We may therefore have isolated a heterogeneous population of cells that can give rise to several lineages. In support of this is the fact that in the spinal cord astrocytes are derived from the dorsal region of the cord (Lu et al., 2002; Pringle et al., 1998; Zhou and Anderson, 2002) , while oligodendrocytes and motoneurons are derived from the ventral region (Hall et al., 1996; Novitch et al., 2001; Pringle et al., 2003) . On the other hand, it has been shown that neurospheres isolated from the same region and stage of the cord that we have used do have characteristics of NSCs; however, this may be due to their expansion in vitro and may not represent the in vivo situation (Gabay et al., 2003) .
Generation of islet-1/2-expressing neurons by the RARs
In order to form mature motoneurons, further retinoid signalling is required. Previous work has shown in vivo that overexpression of a constitutive active retinoid receptor in thoracic motoneurons prevents their differentiation and leads to neuronal death; whereas blocking retinoid signalling in brachial motoneurons inhibits the differentiation of medial lateral motor column neuron, which expresses islet-2 and lim-1, and forces them to become Column of Terni neurons, which express islet-1, and lateral median motor column neurons, which express islet-1/2 (Sockanathan et al., 2003) .
We have shown here that specific RAR receptor pathways are involved in postmitotic neuronal differentiation and that the combinational actions of RAR-signalling control islet-1/2 expression. The initial RA-signalling step for motoneuron differentiation is the activation of RARh (Fig.  8) , which induces islet-1, but not islet-2 expression. Neither RARa nor g activation can induce islet-1 expression to the same levels as RARh activation, even with increasing concentrations. It is unlikely that this is due to a timing issue, as when the NPCs were cultured for 4 days in either RARa or g agonists, islet-1 expression was still not induced to any appreciable extent. This suggests that these signalling pathways cannot substitute for RARh signalling in the initial specification of the motoneurons. However, once this step occurs, then signalling by RARa and g is required for further maturation of the motoneurons. Activated RARa signalling can maintain islet-1 expression in combination with activated RARh (Fig. 8) . When RARa is activated either in the presence or absence of RARh signalling, then islet-2expressing neurons are obtained (Fig. 8 ). However, it is only when RARh expression is down-regulated that there is a dramatic increase in the number of islet-2 neurons produced by RARa signalling. The loss of RARh expression may be due to activated RARg, as this receptor is able to down-regulate RARh. It has also previously been shown that activation of RARh is antagonistic to RARa and g activation (Matt et al., 2003) , and this may be one reason why we see so few islet-2-expressing neurons in the presence of RARh plus RARa agonists. Therefore, while RARa and g do not play a major role in the initial expression of islet-1, they are important for the regulation of islet-2 expression. We have not identified a role for RXR signalling in the regulation of islet/2, although it is thought to be involved in motoneuron maturation (Solomin et al., 1998) . It may be important for the regulation of other LIM homeodomain proteins, known to be involved in motoneuron specification, these include Lim-1 and Lim-3 (Tsuchida et al., 1994) .
One of the final steps in motoneuron maturation is the activation of RARa signalling (Fig. 8) . RARh signalling prevents a mature phenotype occurring, as when this receptor pathway is activated, few if any motoneurons express the p75 receptor. In vivo, it has also been shown that during neurogenesis of the spinal cord, both RARa and RARh correlate with this process (Colbert et al., 1995; Yamagata et al., 1994) , and at its completion RARh expression is down-regulated while RARa expression is maintained (Corcoran et al., 2002; Yamagata et al., 1994) . There is an increase in p75 expression in the absence of RARh signalling in the RARa, g and RXR agonist-treated cultures. However, it is only when the RARa pathway is activated that there is a significant increase in p75expressing motoneurons compared to any of the other Fig. 8 . Model of NPC differentiation in response to retinoid agonists. NPCs differentiate into oligodendrocytes/astrocytes in the presence of RARa and g agonists, the majority being formed in the former. NPCs mainly differentiate into motoneurons in the presence of RARh agonist. Once the motoneuron progenitor is formed, RARa in combination with RARh agonist can maintain islet-1 expression or in its absence can induce islet-2 expression. In the presence of RARa agonist but absence of RARh agonist, mature motoneurons-expressing p75 are obtained.
treatments. This suggests that RARa pathway is required to maintain a mature motoneuron phenotype rather than to induce it (Fig. 8) . Previous work has shown that RA signalling is involved in neurite outgrowth (Quinn and De Boni, 1991) , and that it occurs via activation of RARh signalling (Corcoran et al., 2000) . We have further shown here that neurite outgrowth occurs in the presence of RARh signalling and that in its absence only RARa signalling can maintain this outgrowth. This again shows the importance of RARa signalling in the maintenance of a mature motoneuron phenotype.
Our data, showing that the order of activation of retinoid receptors leads to the differentiation of NPCs into various neural cell types, may now have implications for stem cell therapy. One major problem that has to be overcome before stem cells can be used therapeutically is to generate large numbers of homogenous cells. We have shown here that by delineating the retinoid-signalling pathways required for various neural types, far more cells of a particular lineage can be obtained than by using RA alone. One reason why this may occur is because RA is able to activate all retinoidsignalling pathways in the NPCs at the same time. By using retinoid agonists as illustrated here, the retinoid pathways can be activated in a sequential manner as in vivo, this leads to a far greater number of differentiated cells of one particular phenotype.
